These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38777374)

  • 1. B-cell depletion in autoimmune diseases.
    Schett G; Nagy G; Krönke G; Mielenz D
    Ann Rheum Dis; 2024 Jun; ():. PubMed ID: 38777374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD19 Chimeric Antigen Receptor T Cell Treatment: Unraveling the Role of B Cells in Systemic Lupus Erythematosus.
    Taubmann J; Müller F; Yalcin Mutlu M; Völkl S; Aigner M; Bozec A; Mackensen A; Grieshaber-Bouyer R; Schett G
    Arthritis Rheumatol; 2024 Apr; 76(4):497-504. PubMed ID: 38114423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic tactics for targeting B lymphocytes in autoimmunity and cancer.
    Wemlinger SM; Cambier JC
    Eur J Immunol; 2024 Jan; 54(1):e2249947. PubMed ID: 37816494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B cell depletion therapies in autoimmune diseases: Monoclonal antibodies or chimeric antigen receptor-based therapy?
    Zhang Z; Xu Q; Huang L
    Front Immunol; 2023; 14():1126421. PubMed ID: 36855629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CAR T-cell therapy in autoimmune diseases.
    Schett G; Mackensen A; Mougiakakos D
    Lancet; 2023 Nov; 402(10416):2034-2044. PubMed ID: 37748491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [B lymphocyte].
    Hasegawa M
    Nihon Rinsho Meneki Gakkai Kaishi; 2005 Oct; 28(5):300-8. PubMed ID: 16276043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advancements and challenges in CAR T cell therapy in autoimmune diseases.
    Schett G; Müller F; Taubmann J; Mackensen A; Wang W; Furie RA; Gold R; Haghikia A; Merkel PA; Caricchio R; D'Agostino MA; Locatelli F; June CH; Mougiakakos D
    Nat Rev Rheumatol; 2024 Sep; 20(9):531-544. PubMed ID: 39107407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-cell-targeted therapy for systemic lupus erythematosus.
    Sabahi R; Anolik JH
    Drugs; 2006; 66(15):1933-48. PubMed ID: 17100405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus.
    Eisenberg R; Albert D
    Nat Clin Pract Rheumatol; 2006 Jan; 2(1):20-7. PubMed ID: 16932648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting B cells and plasma cells in autoimmune diseases: From established treatments to novel therapeutic approaches.
    Merino-Vico A; Frazzei G; van Hamburg JP; Tas SW
    Eur J Immunol; 2023 Jan; 53(1):e2149675. PubMed ID: 36314264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-lymphocyte contributions to human autoimmune disease.
    Yanaba K; Bouaziz JD; Matsushita T; Magro CM; St Clair EW; Tedder TF
    Immunol Rev; 2008 Jun; 223():284-99. PubMed ID: 18613843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [B cells as key contributors in determining the level of immune responses -B-cell-targeted therapy in patients with autoimmune diseases].
    Kondo S; Akashi T; Katsuta H; Iwakiri R; Anzai K; Nagafuchi S; Niho Y; Harada M
    Fukuoka Igaku Zasshi; 2005 Apr; 96(4):86-92. PubMed ID: 15991605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine-producing B cells: a translational view on their roles in human and mouse autoimmune diseases.
    Lino AC; Dörner T; Bar-Or A; Fillatreau S
    Immunol Rev; 2016 Jan; 269(1):130-44. PubMed ID: 26683150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B cell-targeting chimeric antigen receptor T cells as an emerging therapy in neuroimmunological diseases.
    Haghikia A; Schett G; Mougiakakos D
    Lancet Neurol; 2024 Jun; 23(6):615-624. PubMed ID: 38760099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulated translational factors and epigenetic regulations orchestrate in B cells contributing to autoimmune diseases.
    Yang M; Yi P; Jiang J; Zhao M; Wu H; Lu Q
    Int Rev Immunol; 2023; 42(1):1-25. PubMed ID: 34445929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-cells and their targeting in rheumatoid arthritis--current concepts and future perspectives.
    Nakken B; Munthe LA; Konttinen YT; Sandberg AK; Szekanecz Z; Alex P; Szodoray P
    Autoimmun Rev; 2011 Nov; 11(1):28-34. PubMed ID: 21777703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B Cell Abnormalities in Systemic Lupus Erythematosus and Lupus Nephritis-Role in Pathogenesis and Effect of Immunosuppressive Treatments.
    Yap DYH; Chan TM
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CD27-CD70 pathway and pathogenesis of autoimmune disease.
    Han BK; Olsen NJ; Bottaro A
    Semin Arthritis Rheum; 2016 Feb; 45(4):496-501. PubMed ID: 26359318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophils contribute to excess serum BAFF levels and promote CD4+ T cell and B cell responses in lupus-prone mice.
    Coquery CM; Wade NS; Loo WM; Kinchen JM; Cox KM; Jiang C; Tung KS; Erickson LD
    PLoS One; 2014; 9(7):e102284. PubMed ID: 25010693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B cell depletion therapy in systemic lupus erythematosus.
    Anolik J; Sanz I; Looney RJ
    Curr Rheumatol Rep; 2003 Oct; 5(5):350-6. PubMed ID: 12967516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.